SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

B. Riley FBR Maintains Buy on Infinity Pharmaceuticals, Lowers Price Target to $2.5

B. Riley FBR maintains Infinity Pharmaceuticals (NASDAQ:INFI) with a Buy and lowers the price target from $3.5 to $2.5.

Benzinga · 05/18/2020 11:39

B. Riley FBR maintains Infinity Pharmaceuticals (NASDAQ:INFI) with a Buy and lowers the price target from $3.5 to $2.5.